Home › Funds › Arrowstreet Capital › ESPR
Arrowstreet Capital position in ESPR
ESPERION THERAPEUTICS INC NE
Latest position (Q4 2021)19.32K sh
Reported value held$97.00K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 19.32K | $97.00K | New |
Other funds holding ESPR
- BlackRock Inc 22.13M sh · $69.92M · Q2 2026
- Vanguard Group 14.95M sh · $55.30M · Q4 2025
- Goldman Sachs Group 10.38M sh · $32.80M · Q2 2026
- Two Sigma Investments 7.13M sh · $22.52M · Q2 2026
- Geode Capital Management 6.63M sh · $20.96M · Q2 2026
- Balyasny Asset Management 4.65M sh · $14.71M · Q2 2026
- Fidelity Management & Research (FMR) 4.61M sh · $14.58M · Q2 2026
- UBS Group AG 3.84M sh · $12.12M · Q2 2026
- Northern Trust Corp 2.32M sh · $7.34M · Q2 2026
- Millennium Management 2.23M sh · $7.03M · Q2 2026
- Fidelity International (FIL) 2.11M sh · $6.66M · Q2 2026
- JPMorgan Chase & Co 1.40M sh · $4.40M · Q2 2026